Connecticut biotech Halda Therapeutics, created by Arvinas founder Craig Crews, has reeled in another $126 million to start clinical testing of its oral molecules for …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
New biotech newsletter launching this Thursday. Don’t miss out. Hey there. Today, we discuss the implications of the Supreme Court’s forthcoming mifepristone evaluation on the
BeyondSpring Inc. is an early-stage clinical trial biopharmaceutical company developing immuno-oncology therapies (anti-cancer drugs). The main pipeline is Plinabulin, an anti-cancer drug that is being
Angling to tap into strong support for the sweeping health law he helped pass 14 years ago, one of President Joe Biden’s latest reelection strategies